| Literature DB >> 25024206 |
Mathias J Wawer1, Kejie Li1, Sigrun M Gustafsdottir1, Vebjorn Ljosa2, Nicole E Bodycombe1, Melissa A Marton3, Katherine L Sokolnicki2, Mark-Anthony Bray2, Melissa M Kemp1, Ellen Winchester3, Bradley Taylor3, George B Grant3, C Suk-Yee Hon1, Jeremy R Duvall4, J Anthony Wilson1, Joshua A Bittker4, Vlado Dančík5, Rajiv Narayan6, Aravind Subramanian6, Wendy Winckler3, Todd R Golub6, Anne E Carpenter2, Alykhan F Shamji1, Stuart L Schreiber7, Paul A Clemons7.
Abstract
High-throughput screening has become a mainstay of small-molecule probe and early drug discovery. The question of how to build and evolve efficient screening collections systematically for cell-based and biochemical screening is still unresolved. It is often assumed that chemical structure diversity leads to diverse biological performance of a library. Here, we confirm earlier results showing that this inference is not always valid and suggest instead using biological measurement diversity derived from multiplexed profiling in the construction of libraries with diverse assay performance patterns for cell-based screens. Rather than using results from tens or hundreds of completed assays, which is resource intensive and not easily extensible, we use high-dimensional image-based cell morphology and gene expression profiles. We piloted this approach using over 30,000 compounds. We show that small-molecule profiling can be used to select compound sets with high rates of activity and diverse biological performance.Keywords: biological activity; biological performance diversity; chemical diversity; chemical similarity
Mesh:
Year: 2014 PMID: 25024206 PMCID: PMC4121832 DOI: 10.1073/pnas.1410933111
Source DB: PubMed Journal: Proc Natl Acad Sci U S A ISSN: 0027-8424 Impact factor: 11.205